15.07.2025

Vaxxinova announced the acquisition of Deltamune (Pty) Ltd (South Africa) from Phatisa.
Deltamune is a leading animal health company in South Africa, specializing in solutions for African livestock. The company possesses in-house research, development, and production capabilities for both licensed and autogenous vaccines, serving markets across Sub-Saharan Africa.
This acquisition follows Vaxxinova’s recent purchase of Dechra’s vaccine operations.